Literature DB >> 31072620

Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection.

S Di Sandro1, L Benuzzi2, A Lauterio2, F Botta3, R De Carlis4, M Najjar5, L Centonze6, M Danieli2, I Pezzoli2, A Rampoldi6, V Bagnardi3, L De Carlis7.   

Abstract

INTRODUCTION: Patients with a single small Hepatocellular Carcinoma (HCC) may be definitively treated by Radiofrequency ablation (RFA) with a very low rate of peri-operative morbidity. However, results are still controversial comparing RFA to Liver Resection (LR).
METHODS: All consecutive patients treated by RFA or LR for a single untreated small HCC on liver cirrhosis between January 2006-December 2016 were enrolled. Patients were matched 1:1 basing on: age, MELD-score, platelet count, nodule's diameter, HCV status, α-fetoprotein level, and Albumin-Bilirubin score. First analysis compered LR to RFA. Second analysis compared Laparoscopic LR (LLR) to RFA.
RESULTS: Of 484 patients with single small HCC, 91 patients were selected for each group after a 1:1 propensity score matching (PS-M). The 5-years OS was 70% and 60% respectively for LR and RFA group (P = 0.666). The 5-year RFS was 36% and 21% respectively for LR and RFA group (P < 0.001). Patients treated by LR had a significantly longer hospital stay and higher complications rate. Comparing 50 cases of LLR and 50 of RFA, the 5-years OS was 79% and 56% respectively for LLR and RFA group (P = 0.22). The 5-year RFS was 54% and 19% respectively for LR and RFA group (P < 0.001). Post-operative complications were not significantly different.
CONCLUSIONS: LLR confers similar peri-operative complications rate compared to RFA. LLR should be considered as a first-line approach for the treatment of a single small HCC as it combines the effectiveness of open LR and the safety profile of RFA.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; Laparoscopy; Liver resection; Radiofrequency ablation

Mesh:

Year:  2019        PMID: 31072620     DOI: 10.1016/j.ejso.2019.04.023

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

1.  Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma.

Authors:  Angelo Della Corte; Claudio Sallemi; Francesca Ratti; Lorenzo Monfardini; Simone Gusmini; Federica Cipriani; Renato Pennella; Domenico Santangelo; Valentina Burgio; Andrea Casadei-Gardini; Luca Aldrighetti; Francesco De Cobelli
Journal:  Cardiovasc Intervent Radiol       Date:  2022-09-30       Impact factor: 2.797

2.  Comparison of the safety and efficacy of hepatic resection and radiofrequency ablation in the treatment of single small hepatocellular carcinoma: systematic review and meta-analysis.

Authors:  Ke Wang; Rui Wang; Siqin Liu; Guoqing Peng; Huan Yu; Xiaomei Wang
Journal:  Transl Cancer Res       Date:  2022-03       Impact factor: 1.241

3.  Radiofrequency ablation guided by cone beam computed tomography for hepatocellular carcinoma: a comparative study of clinical results with the conventional spiral computed tomography-guided procedure.

Authors:  Tianshi Lyu; Jian Wang; Shoujin Cao; Li Song; Xiaoqiang Tong; Yinghua Zou
Journal:  J Int Med Res       Date:  2019-06-27       Impact factor: 1.671

4.  A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma.

Authors:  Krizia Pocino; Cecilia Napodano; Mariapaola Marino; Riccardo Di Santo; Luca Miele; Nicoletta De Matthaeis; Francesca Gulli; Raffaele Saporito; Gian Ludovico Rapaccini; Gabriele Ciasca; Umberto Basile
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.639

5.  Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer.

Authors:  Vincenzo Ronca; Matteo Barabino; Roberto Santambrogio; Enrico Opocher; James Hodson; Emanuela Bertolini; Simone Birocchi; Gaetano Piccolo; PierMaria Battezzati; Marco Cattaneo; Gian Marco Podda
Journal:  Hepatol Commun       Date:  2021-10-30

Review 6.  Efficacy and safety of various primary treatment strategies for very early and early hepatocellular carcinoma: a network meta-analysis.

Authors:  Sha Yang; Huapeng Lin; Jianning Song
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

7.  A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.

Authors:  Shu-Wen Zhang; Ning-Ning Zhang; Wen-Wen Zhu; Tian Liu; Jia-Yu Lv; Wen-Tao Jiang; Ya-Min Zhang; Tian-Qiang Song; Li Zhang; Yan Xie; Yong-He Zhou; Wei Lu
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

Review 8.  The Endless Sources of Hepatocellular Carcinoma Heterogeneity.

Authors:  Marina Barcena-Varela; Amaia Lujambio
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

9.  Radiofrequency ablation versus repeat hepatectomy in the treatment of recurrent hepatocellular carcinoma in subcapsular location: a retrospective cohort study.

Authors:  Fuqun Wei; Qizhen Huang; Yang Zhou; Liuping Luo; Yongyi Zeng
Journal:  World J Surg Oncol       Date:  2021-06-14       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.